These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 165604)

  • 1. A clinical impression of Actinac in tropical acne.
    Bentley-Phillips B
    Trop Doct; 1975 Apr; 5(2):93-6. PubMed ID: 165604
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acne vulgaris comparing two similar lotion formulations, one with ('Actinac') and one without chloramphenicol.
    Fraser NB; Main RA; Stewart TW; Thornton EJ
    Curr Med Res Opin; 1980; 6(7):461-5. PubMed ID: 6444862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of Actinac in acne.
    MacDonald RH; McGrath H; Ray SK
    Br J Clin Pract; 1976 Oct; 30(10):194-6. PubMed ID: 136977
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Tretinoin and a composite formulation in the treatment of acne.
    Brookes DB; Moffitt RM; Sheil LP; Flowers IM; Poulter GA
    Br J Clin Pract; 1978 Dec; 32(12):349-52. PubMed ID: 153763
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical observations on the action of a new drug against acne].
    Fuga GC
    Minerva Med; 1967 Apr; 58(29):1241-4. PubMed ID: 4228593
    [No Abstract]   [Full Text] [Related]  

  • 6. The only topical retinoid without a generic alternative: tazarotene.
    Kircik LH
    J Drugs Dermatol; 2013 Mar; 12(3):s52. PubMed ID: 23545934
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion.
    Breneman DL; Ariano MC
    Int J Dermatol; 1993 May; 32(5):365-7. PubMed ID: 8505165
    [No Abstract]   [Full Text] [Related]  

  • 8. Tazarotene foam, 0.1%, for the treatment of acne.
    Smith JA; Narahari S; Hill D; Feldman SR
    Expert Opin Drug Saf; 2016 Jan; 15(1):99-103. PubMed ID: 26560170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution to the local treatment of acne vulgaris].
    Eberhartinger C
    Wien Med Wochenschr; 1969 Jan; 119(2):25-7. PubMed ID: 4388694
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of topical drugs in treatment of noninflammatory acne vulgaris.
    Merkviladze N; Gaidamashvili T; Tushurashvili P; Ekaladze E; Jojua N
    Georgian Med News; 2010 Sep; (186):46-50. PubMed ID: 20972276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs for acne vulgaris.
    Med Lett Drugs Ther; 1971 Mar; 13(6):23-4. PubMed ID: 4254338
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-acne].
    Verschoore M; Poncet M; Schaefer H; Revuz J; De Prost Y; Guillaume JC; Ortonne JP; Czernielewski J
    Therapie; 1991; 46(3):189-91. PubMed ID: 1838841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D; Arsonnaud S; Soto P
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosac Cream With Sunscreens (sodium sulfacetamide 10% and sulfur 5%).
    Lebrun CM
    Skinmed; 2004; 3(2):92. PubMed ID: 15010634
    [No Abstract]   [Full Text] [Related]  

  • 16. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
    Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial.
    Leyden J; Lowe N; Kakita L; Draelos Z
    Cutis; 2001 Jun; 67(6 Suppl):10-6. PubMed ID: 11499327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical therapeutic action of azelaic acid in polymorphous acne].
    Troccoli T; Florio T; Petruzzellis V
    G Ital Dermatol Venereol; 1989 Oct; 124(10):485-91. PubMed ID: 2534554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
    J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene (tazorac) for acne.
    Med Lett Drugs Ther; 2002 Jun; 44(1132):52-3. PubMed ID: 12058150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.